Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.4M Sell
19,449
-57,519
-75% -$5.41M 0.05% 144
2026
Q1
$9.1M Sell
76,968
-3,584
-4% -$443K 0.37% 89
2025
Q4
$10.1M Buy
80,552
+4,496
+6% +$586K 1.46% 18
2025
Q3
$11.1M Buy
76,056
+12,886
+20% +$1.95M 1.57% 17
2025
Q2
$9.85M Buy
63,170
+31,949
+102% +$5.07M 1.39% 20
2025
Q1
$5.14M Sell
31,221
-349
-1% -$58K 0.92% 25
2024
Q4
$5.14M Buy
31,570
+13,641
+76% +$2.44M 0.89% 33
2024
Q3
$3.5M Sell
17,929
-282
-2% -$52K 0.61% 40
2024
Q2
$3.16M Hold
18,211
0.58% 42
2024
Q1
$3.08M Buy
18,211
+15,225
+510% +$2.85M 0.55% 41
2023
Q4
$589K Buy
+2,986
New +$529K 0.12% 59

Other funds holding ZTS

Mirova's ZTS Position: Q2 2026 in Review

Mirova reduced its Zoetis (ZTS) stake by 75% in Q2 2026, selling an estimated $5.41M and leaving 19,449 shares worth $1.4M. The position accounts for 0.05% of the portfolio, ranked #144.

Mirova first reported a position in ZTS in Q4 2023 and has held it in 11 quarters since. The position peaked at $11.1M in Q3 2025. 1,422 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Mirova held 19,449 shares of Zoetis worth $1.4M as of Q2 2026.
  • Mirova sold 57,519 Zoetis shares in Q2 2026, an estimated $5.41M.
  • Zoetis made up 0.05% of Mirova's portfolio in Q2 2026, its #144 holding.
  • Mirova first reported a position in Zoetis in Q4 2023 and has held it in 11 quarters since.
  • Mirova's Zoetis position peaked at $11.1M in Q3 2025.
  • 1,422 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Mirova's 13F filing for Q2 2026, filed 13 Aug 2026.